Search details
1.
Cost-effectiveness of implant movement analysis in aseptic loosening after hip replacement: a health-economic model.
Cost Eff Resour Alloc
; 21(1): 88, 2023 Nov 20.
Article
in English
| MEDLINE | ID: mdl-37986000
2.
Liposomal daunorubicin, fludarabine, and cytarabine (FLAD) as bridge therapy to stem cell transplant in relapsed and refractory acute leukemia.
Ann Hematol
; 93(12): 2011-8, 2014 Dec.
Article
in English
| MEDLINE | ID: mdl-24989345
3.
De novo AML patients with favourable-intermediate karyotype may benefit from the addition of low-dose gemtuzumab ozogamicin (GO) to fludarabine, Ara-C and idarubicin (FLAI): a contribution to the reopened "GO question".
Ann Hematol
; 92(10): 1309-18, 2013 Oct.
Article
in English
| MEDLINE | ID: mdl-23686116
4.
Dual NAMPT and BTK Targeting Leads to Synergistic Killing of Waldenström Macroglobulinemia Cells Regardless of MYD88 and CXCR4 Somatic Mutation Status.
Clin Cancer Res
; 22(24): 6099-6109, 2016 Dec 15.
Article
in English
| MEDLINE | ID: mdl-27287071
5.
Mechanisms and Clinical Applications of Genome Instability in Multiple Myeloma.
Biomed Res Int
; 2015: 943096, 2015.
Article
in English
| MEDLINE | ID: mdl-26579543
Results
1 -
5
de 5
1
Next >
>>